Gamma Investing LLC Repligen Corp Transaction History
Gamma Investing LLC
- $1.17 Trillion
- Q4 2024
A detailed history of Gamma Investing LLC transactions in Repligen Corp stock. As of the latest transaction made, Gamma Investing LLC holds 684 shares of RGEN stock, worth $106,279. This represents 0.01% of its overall portfolio holdings.
Number of Shares
684
Previous 594
15.15%
Holding current value
$106,279
Previous $88.4 Million
11.38%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.18 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.11 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$793 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$263 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$240 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.62B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....